Effects of Adrenergic Blockade on Serum Potassium Changes in Response to Acute Insulin-Induced Hypoglycemia in Nondiabetic Humans
- B Miles Fisher, MD,
- Ian Thomson, BSc,
- David A Hepburn, MRCP and
- Brian M Frier, MD
- Diabetic Department, Western Infirmar∕Gartnavel General Hospital Glasgow, Scotland MRC Blood Pressure Unit, Western Infirmary Glasgow, Scotland, United Kingdom
- Address correspondence and reprint requests to B. Miles Fisher, MD, Wards 4⁄5, Royal Infirmary, Glasgow G4 OSF, Scotland, UK.
Abstract
Objective To determine the possible role of adrenergic mechanisms in mediating the fall in serum potassium concentration after intravenous injection of insulin.
Research Design and Methods Eighteen nondiabetic male volunteers, divided into three groups of six subjects, comprised the study. Hypoglycemia was induced by a bolus of short-acting insulin (0.15 U∕kg body wt). Six subjects were studied in control conditions, six during α-adrenergic blockade with phentolamine, and six during β-adrenergic blockade with propranolol.
Results In the control group, there was an immediate fall in serum potassium from 4.0 ± 0.1 to 3.6 ± 0.1 mM at baseline + 15 min. After the onset of acute hypoglycemia, potassium decreased further in the control group, reaching a lowest concentration of 3.3 ± 0.1 mM. In the propranolol group, the late decrease in potassium was inhibited, and there were no further changes in serum potassium. During α-blockade, there was an exaggerated fall to 2.6 ± 0.1 mM at 30 min after the onset of hypoglycemia.
Conclusions The later fall in serum potassium, which occurs after the onset of hypoglycemia, is probably mediated by stimulation of β-adrenoreceptors, whereas coincidental stimulation of α-adrenoreceptors opposes this fall in potassium and may prevent the development of severe hypokalemia in response to acute hypoglycemia.
- Received April 2, 1990.
- Accepted February 25, 1991.
- Copyright © 1991 by the American Diabetes Association











